Filter Results
:
(277)
Show Results For
-
All HBS Web
(1,149)
- Faculty Publications (277)
Show Results For
-
All HBS Web
(1,149)
- Faculty Publications (277)
- November 2006 (Revised March 2007)
- Case
Goodyear and the Threat of Government Tire Grading
By: Felix Oberholzer-Gee, Dennis A. Yao and Elizabeth Raabe
In the spring of 1977, Goodyear CEO Charles J. Pilliod Jr. was looking at an internal report on government and legal events relevant to the tire industry. Two items caught his attention. First, he noticed that an industry suit to block the government's proposed system...
View Details
Keywords:
Competitive Advantage;
Lawsuits and Litigation;
Auto Industry;
Rubber Industry;
United States
Oberholzer-Gee, Felix, Dennis A. Yao, and Elizabeth Raabe. "Goodyear and the Threat of Government Tire Grading." Harvard Business School Case 707-494, November 2006. (Revised March 2007.)
- October 2006 (Revised August 2007)
- Case
Calloway Laboratory: Pee for Profit
By: Richard G. Hamermesh and David Kiron
Describes the formation and rapid growth of a drug-testing company. The company needs to decide whether to enter the painkiller testing market, in addition to growing its drug treatment center business.
View Details
Keywords:
For-Profit Firms;
Health Care and Treatment;
Health Testing and Trials;
Growth and Development Strategy;
Market Entry and Exit;
Health Industry
Hamermesh, Richard G., and David Kiron. "Calloway Laboratory: Pee for Profit." Harvard Business School Case 807-040, October 2006. (Revised August 2007.)
- 2006
- Other Unpublished Work
Does Competition Increase Patent Litigation? Empirical Evidence of Strategic Patenting in the Telecom Equipment Industry
By: Juan Alcacer and Rachelle C. Sampson
Anecdotal evidence suggests that patent litigation has increased in the last 20 years as firms in knowledge intensive industries use patents more frequently to protect their knowledge stocks and managers focus on extracting new revenue streams from existing patent...
View Details
- May 2006 (Revised October 2007)
- Case
EU Verdict Against Microsoft
By: David B. Yoffie and Michael Slind
In 2004, following an investigation that began in 1998, the European Commission (EC) issued an antitrust judgment against Microsoft Corp., levying a record fine of 497 million euros ($613 million) and mandating changes of commercial behavior and bundling of Windows...
View Details
Keywords:
Judgments;
Governance Compliance;
Lawsuits and Litigation;
Monopoly;
Business and Government Relations;
Competitive Strategy;
Software;
European Union;
United States
Yoffie, David B., and Michael Slind. "EU Verdict Against Microsoft." Harvard Business School Case 706-503, May 2006. (Revised October 2007.)
- January 2006 (Revised May 2007)
- Supplement
Endo Pharmaceuticals (F): Appeals Court Ruling
By: Richard G. Hamermesh and Brian DeLacey
Hamermesh, Richard G., and Brian DeLacey. "Endo Pharmaceuticals (F): Appeals Court Ruling." Harvard Business School Supplement 806-082, January 2006. (Revised May 2007.)
- January 2006 (Revised July 2006)
- Case
Drug Testing in Nigeria (A)
By: Debora L. Spar
In 1996, a meningitis epidemic swept across Nigeria. Thousands of children were struck and, lacking appropriate medicine, were liable to die from the disease. Doctors at Pfizer had an antibiotic that could probably save most of these children's lives. The drug was new,...
View Details
Keywords:
Risk and Uncertainty;
Health Pandemics;
Health Testing and Trials;
Developing Countries and Economies;
Pharmaceutical Industry;
Nigeria
Spar, Debora L., and Adam Day. "Drug Testing in Nigeria (A)." Harvard Business School Case 706-033, January 2006. (Revised July 2006.)
- December 2005 (Revised April 2007)
- Case
Flagstar Companies, Inc. (Abridged)
By: Stuart C. Gilson
A large restaurant chain undergoes a leveraged buyout and subsequent recapitalization. Financial and operating problems at the company force it to consider various restructuring options, including a prepackaged Chapter 11 exchange offer to its public bondholders. Two...
View Details
Keywords:
Leveraged Buyouts;
Restructuring;
Capital;
Insolvency and Bankruptcy;
Debt Securities;
Competition;
Valuation;
Financial Services Industry;
United States
Gilson, Stuart C. "Flagstar Companies, Inc. (Abridged)." Harvard Business School Case 206-076, December 2005. (Revised April 2007.)
- August 2005 (Revised December 2006)
- Case
Procter & Gamble: Electronic Data Capture and Clinical Trial Management
By: Robert S. Huckman and Mark J. Cotteleer
Considers whether the management of Procter & Gamble (P&G) Pharmaceuticals should adopt Web-based electronic data capture (EDC) as the default standard for the management of its clinical drug trials. Provides a detailed description of the existing paper-based process...
View Details
Keywords:
Health Testing and Trials;
Internet and the Web;
Information Technology;
Adoption;
Business Processes;
Industry Structures;
Technological Innovation;
Service Operations;
Pharmaceutical Industry;
United States
Huckman, Robert S., and Mark J. Cotteleer. "Procter & Gamble: Electronic Data Capture and Clinical Trial Management." Harvard Business School Case 606-033, August 2005. (Revised December 2006.)
- July 2005
- Background Note
Guth v. Loft: Synopsis
By: Lynn S. Paine and Christopher Bruner
Provides a brief overview of the Supreme Court of Delaware's opinion in the 1939 case of Guth v. Loft, a widely cited application of the "corporate opportunity doctrine." Explores the corporate law principles regulating when a corporate manager can or cannot take...
View Details
Paine, Lynn S., and Christopher Bruner. "Guth v. Loft: Synopsis." Harvard Business School Background Note 306-015, July 2005.
- 2005
- Working Paper
Does Focus Improve Operational Performance? Lessons from the Management of Clinical Trials
By: Robert S. Huckman and Darren E. Zinner
Huckman, Robert S., and Darren E. Zinner. "Does Focus Improve Operational Performance? Lessons from the Management of Clinical Trials." Harvard Business School Working Paper, No. 05-073, May 2005.
- February 2005 (Revised April 2006)
- Case
Rx Depot: Importing Drugs from Canada
By: Debora L. Spar
In 2002, a handful of entrepreneurs began to ship drugs from Canada into the United States, taking advantage of regulatory and price differentials across the neighboring countries. Using the Internet and a low-cost network of Canadian pharmacies, firms like Rx Depot...
View Details
Keywords:
Courts and Trials;
Entrepreneurship;
Intellectual Property;
Laws and Statutes;
Pharmaceutical Industry;
Canada;
United States
Spar, Debora L., and Adam Day. "Rx Depot: Importing Drugs from Canada." Harvard Business School Case 705-010, February 2005. (Revised April 2006.)
- 2005
- Government Testimony
Brief Amici Curiae: Supreme Court of the United States, Metro-Goldwyn-Mayer Studios, Inc., et al., v. Grokster, Ltd., et al.
By: Felix Oberholzer-Gee and Koleman Strumpf
- March 2004 (Revised May 2004)
- Case
Governance Reform at MCI
By: Lynn S. Paine and Bridget Gurtler
Richard Breeden proposed corporate governance reforms for MCI. Breeden is a former chairman of the SEC who was a court-appointed "corporate monitor" for the troubled company (formerly WorldCom). The company must adhere to the proposals unless excused by a court order.
View Details
Keywords:
Corporate Governance;
Restructuring;
Insolvency and Bankruptcy;
Business or Company Management;
Management Teams
Paine, Lynn S., and Bridget Gurtler. "Governance Reform at MCI." Harvard Business School Case 304-066, March 2004. (Revised May 2004.)
- December 2003 (Revised August 2006)
- Background Note
Grutter v. Bollinger: A Synopsis
By: Lynn S. Paine
In June 2003, the U.S. Supreme Court announced its decision in Grutter v. Bollinger, upholding the principle of affirmative action in university admissions, which had been challenged as a violation of the U.S. Constitution's Fourteenth Amendment. This case includes...
View Details
Keywords:
Lawsuits and Litigation
Paine, Lynn S. "Grutter v. Bollinger: A Synopsis." Harvard Business School Background Note 304-065, December 2003. (Revised August 2006.)
- November 2003 (Revised September 2008)
- Case
Circle Gastroenterology Products (A)
By: Regina E. Herzlinger and James Weber
A new, minimally invasive medical device has achieved only one-third of its budget. Was the problem one of marketing strategy, sales, reimbursement, and/or clinical trials?
View Details
Keywords:
Health Testing and Trials;
Marketing Strategy;
Product Marketing;
Sales;
Medical Devices and Supplies Industry
Herzlinger, Regina E., and James Weber. "Circle Gastroenterology Products (A)." Harvard Business School Case 304-052, November 2003. (Revised September 2008.)
- October 2003 (Revised January 2004)
- Exercise
Electric Maze Exercise, The
By: Amy C. Edmondson and Hanna Rodriguez-Farrar
This team-based exercise uses an educational tool called "The Electric Maze," developed by Interel Corp., to teach insights about the social and psychological challenges facing employees who must engage in collaborative learning. The tool is a grid-patterned rug with...
View Details
Edmondson, Amy C., and Hanna Rodriguez-Farrar. "Electric Maze Exercise, The." Harvard Business School Exercise 604-046, October 2003. (Revised January 2004.)
- October 2003 (Revised November 2003)
- Module Note
Organizing to Learn Module Note
By: Amy C. Edmondson
Teaches a framework for managing in dynamic or uncertain organizational contexts, designed for either MBA or Executive Education courses. Offers a new perspective on how managers can help stimulate and guide a collective learning process in their organizations. The...
View Details
Edmondson, Amy C. "Organizing to Learn Module Note." Harvard Business School Module Note 604-031, October 2003. (Revised November 2003.)
- August 2003 (Revised July 2023)
- Case
Fighting the Battle of the Bulge—Evaluating Do Good/Do Well Innovations in Morbid Obesity Treatment
By: Regina E. Herzlinger and John McDonough
What can Dr. Dean Ornish learn from the successes and failures of his competitors in ameliorating morbid obesity to create a business model that will “do good” by combatting obesity and associated chronic diseases and “do well” by growing a widely adopted business?...
View Details
Keywords:
Three Pillars;
Industry Analysis;
Health Disorders;
Health Care and Treatment;
Innovation and Invention;
Business Model;
Analysis;
Innovation and Management;
Medical Specialties;
Mission and Purpose;
Health Industry
Herzlinger, Regina E., and John McDonough. "Fighting the Battle of the Bulge—Evaluating Do Good/Do Well Innovations in Morbid Obesity Treatment." Harvard Business School Case 304-009, August 2003. (Revised July 2023.)
- July 2003 (Revised February 2004)
- Background Note
M&A Legal Context: Standards Related to the Sale or Purchase of a Company
By: Carliss Y. Baldwin, Constance E. Bagley and James Quinn
Introduces students to the legal standards affecting officers and directors when selling or purchasing a company. Provides a practical understanding of the Revlon Standard, the Securities and Exchange Act of 1934, Rule 10b-5, and the legal criteria for a cause of...
View Details
Keywords:
Laws and Statutes;
Law Enforcement;
Government Legislation;
Acquisition;
Business Exit or Shutdown;
Corporate Governance;
Going Public;
Courts and Trials
Baldwin, Carliss Y., Constance E. Bagley, and James Quinn. "M&A Legal Context: Standards Related to the Sale or Purchase of a Company." Harvard Business School Background Note 904-004, July 2003. (Revised February 2004.)
- summer 2003
- Article
Patents, Invalidity, and the Strategic Transmission of Enabling Information
By: James J. Anton and Dennis A. Yao
The patent system encourages innovation and knowledge disclosure by providing exclusivity to inventors. Exclusivity is limited, however, because a substantial fraction of patents have some probability of being ruled invalid when challenged in court. The possibility of...
View Details
Keywords:
System;
Innovation and Invention;
Knowledge Dissemination;
Courts and Trials;
Competition;
Patents;
Corporate Disclosure
Anton, James J., and Dennis A. Yao. "Patents, Invalidity, and the Strategic Transmission of Enabling Information." Journal of Economics & Management Strategy 12, no. 2 (summer 2003): 151–178. (Harvard users click here for full text.)